Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: The suita study

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2397-2403

  Okamoto, A ^a   Sakata, T ^a   Mannami, T ^a   Baba, S ^a,c   Katayama, Y ^a   Matsuoh, H ^a,d   Yasaka, M ^a   Minematsu, K ^a   Tomoike, H ^a   Miyatak, T ^b  

^a Laboratory of Clinical Chemistry   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c The Second Hanwa Hospital   (Japan)

^d Matsuo Cardiovascular Clinic   (Japan)

Author keywords

Deep vein thrombosis; Genetic variant; Plasminogen deficiency; Risk factor

Indexed keywords

ANTIGEN; PLASMINOGEN;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; EPIDEMIOLOGY; FEMALE; GENETIC PREDISPOSITION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PREVALENCE; THROMBOSIS;

AGED; ANTIGENS; CASE-CONTROL STUDIES; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN; PREVALENCE; THROMBOSIS;

EID: 4444277941     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00419.x     Document Type: Article

References (31)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B,Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: part 1. Thromb Haemost 1996; 76: 651-62.
2. Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen. J Clin Invest 1978; 61: 1186-95.
3. Sakata Y, Aoki N. Molecular abnormality of plasminogen. J Biol Chem 1980; 255: 5442-7.
4. Miyata T, Iwanaga S, Sakata Y, Aoki N. Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. Proc Natl Acad Sci USA 1982; 79: 6132-6.
5. Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasmino gen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991; 88: 115-9.
6. Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for detection of plasminogen variants. Biochem Genet 1984; 22: 871-81.
7. Shinmyozu K, Maruyama Y, Osame M, Igata A, Ohkatsu Y Frequency and clinical significance of congenital plasminogen abnormality in cerebral infarction. Rinsho Shinkeigaku 1986; 26: 257-60.
8. Kikuchi S, Yamanouchi Y, Li L, Kobayashi K, Ijima H, Miyazaki R, Tsuchiya S, Hamaguchi H. Plasminogen with type-I mutation is poly morphic in the Japanese population. Hum Genet 1992; 90: 7-11.
9. Ooe A, Kida M, Yamazaki T, Park SC, Hamaguchi H, Girolami A, Ichinose A. Common mutation of plasminogen detected in three Asian populations by an amplification refractory mutation system and rapid automated capillary electrophoresis. Thromb Haemost 1999; 82: 1342-6.
10. Tsutsumi S, Saito T, Sakata T, Miyata T, Ichinose A. Genetic diagnosis of dysplasminogenemia: detection of an Ala601-Thr mutation in 118 out of 125 families and identification of a new Asp676-Asn mutation. Thromb Haemost 1996; 76: 135-8.
11. Li L, Kikuchi S, Arinami T, Kobayashi K, Tsuchiya S, Hamaguchi H. Plasminogen with type-I mutation in the Chinese Han population. Clin Genet 1994; 45: 285-7.
12. Takeda-Shitaka M, Umeyama H. Elucidation of the cause for reduced activity of abnormal human plasmin containing an Ala55-Thr mutation: importance of highly conserved Ala55 in serine proteases. FEBS Lett 1998; 425: 448-52.
13. Azuma H, Uno Y, Shigekiyo T, Saito S. Congenital plasminogen defi ciency caused by a Ser572 to Pro mutation. Blood 1993; 82: 475-80.
14. Mima N, Azuma H, Shigekiyo T, Saito S. A novel missense mutation in two families with congenital plasminogen deficiency: identification of an Ala675 to Thr675 substitution. Thromb Haemost 1996;75: 96-100.
15. Schuster V, Mingers AM, Seidenspinner S, Nussgens Z, Pukrop T, Kreth HW. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 1997; 90: 958-66.
16. Schuster V, Zeitler P, Seregard S, Ozcelik U, Anadol D, Luchtman Jones L, Meire F, Mingers AM, Schambeck C, Kreth HW. Homozygous andcompound-heterozygous type I plasminogen deficiencyisa common cause of ligneous conjunctivitis. Thromb Haemost 2001; 85: 1004-10.
17. Demarmels Biasiutti F, Sulzer I, Stucki B, Wuillemin WA, Furlan M, Lammle B. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members. Thromb Hae most 1998; 80: 167-70.
18. Tait RC, Walker ID, Conkie JA, Islam SI, McCall F. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 1996; 76: 1004-8.
19. Shigekiyo T, Kanazuka M, Aihara K, Azuma H, Ohshima Y, Horie H, Nakahira H, Takeichi T, Matsumoto T. No increased risk of thrombosis in heterozygous congenital dysplasminogenemia. Int J Hematol 2000; 72: 247-52.
20. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolu tion ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke 1997; 28: 518-25.
21. Mannami T, Baba S, Ogata J. Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study. Stroke 2000; 31: 2958-65.
22. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of maj or coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160: 2297-303.
23. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 2000; 31: 817-21.
24. Pabinger I, Allaart CF, Hermans J, Briet E, Bertina RM, Protein C transmitter Study Group Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC subcommittee on protein C and protein S. Thromb Haemost 1992; 68: 470-4.
25. Tait RC, Walker ID, Conkie JA, Islam SIAM, McCall F, Mitchell R, Davidson JF. Plasminogen levels in healthy volunteers-influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1992; 68: 506-10.
26. Nicolaes GAF, Dahlback B. Factor V and thrombotic disease: description of a Janus-faced protein. Arterioscler Thromb Vase Biol 2002; 22: 530-8.
27. Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
28. Bugge T.H. Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Gene Dev 1995; 9: 794-807.
29. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-93.
30. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 1997; 185: 963-8.
31. Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M, Carmeliet P. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000; 156: 1865-73.